Atlas Trials

Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome

Clinical trial NCT02834793 · TERMINATED

Trial details

NCT number
NCT02834793
Sponsor
Eisai Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Lennox-Gastaut Syndrome (LGS)
Start date
2016-12-13
Primary completion
2021-05-26
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.